GSK looks for covid jab approval as it prepares to spin off consumer arm February 23, 2022 GlaxoSmithKline and French drugmaker Sanofi have announced they are seeking regulatory approvals for their joint covid vaccine as the firms scramble to catch up with competitors after a series of delays.
GlaxoSmithKline revels in £8.8bn profit ahead of consumer healthcare demerger February 9, 2022 GlaxoSmithKline (GSK) has reported full-year sales of £34bn, boosted by strong pharmaceutical sales over the past 12 months.
GSK science chief to depart as pharma giant looks to revamp drugs pipeline January 19, 2022 GlaxoSmithKline's chief scientific officer Hal Barron will leave the firm this year to join a Silicon Valley anti-ageing start up.
Bankers prepare £25bn package as private equity firms circle GSK January 17, 2022 Bankers are putting together major financing packages in preparation of a potential private equity bid for GlaxoSmithKline’s consumer healthcare business.
‘Marmite situation’ for GSK investors as Unilever bids spark potential bidding war January 17, 2022 Analysts have predicted a potential bidding war erupting for GSK’s consumer arm.
Unilever share price dives 7 per cent as £50bn battle for GlaxoSmithKline’s consumer business begins in earnest January 17, 2022 The main City story this morning is the £50bn bid by Unilever for GlaxoSmithKline’s consumer healthcare business, of which it owns a 68 per cent stake along with Pfizer, which Glaxo said it had rejected. “No doubt in the hope that Unilever will come back with a higher offer, with the sum of £60bn being [...]
Healthcare regulator approves GlaxoSmithKline drug for severely ill Covid patients in UK December 2, 2021 A drug treatment which, the makers say, works against the new Omicron variant of Covid-19, has been approved by UK regulators. Xevudy (sotrovimab), made by pharmaceutical giant GlaxoSmithKline (GSK), has been found to cut hospital admission and death by 79% in those at risk. The monoclonal antibody has been authorised by the Medicines and Healthcare [...]
GSK poaches vaccine executive from Pfizer November 30, 2021 GlaxoSmithKline has poached a Pfizer vaccine executive after failing to bring its own Covid jab to market during the pandemic.
GSK quashes reports of private equity interest in consumer health division October 27, 2021 Pharmaceuticals giant GSK has stuck to its plan to spin off its consumer health division next year as it released its third quarter results this afternoon, quashing reports that private equity giants were plotting to swoop in on the business. GSK has pressed ahead with its plan to spin off its consumer health division in [...]
GSK waves goodbye to West London as breakup begins with new £120m HQ October 11, 2021 GlaxoSmithKline will move its global headquarters to a new £120m site, as the pharmaceutical giant prepares to split up its empire into two separate businesses. The company today announced plans for a shiny new £120m headquarters in Weybridge for its new independent consumer healthcare company. Remaining pharmaceuticals and vaccine staff will also relocate from the [...]
